Stocklytics Platform
Asset logo for symbol RXST
RxSight
RXST73
$33.68arrow_drop_down1.57%-$0.53
High Growth
Asset logo for symbol RXST
RXST73

$33.68

arrow_drop_down1.57%

Income Statement (RXST)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT-$6.32M-$6.05M-$9.08M-$9.19M-$13.64M
EBITDA-$5.17M-$5.23M-$7.94M-$8.10M-$12.51M
gross Profit$25.22M$24.25M$20.68M$17.65M$13.73M
NET Income-$6.33M-$6.07M-$9.10M-$9.17M-$12.41M
total Revenue$45.40M$34.88M$29.51M$28.58M$30.66M

Balance Sheet (RXST)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt-$5.41M-$13.03M-$30.12M-$6.68M-$6.52M
stockholders Equity$277.26M$275.20M$163.92M$160.36M$161.47M
total Assets$310.46M$305.49M$183.16M$182.55M$181.85M
total Debt$11.30M$11.41M$2.52M$3.01M$3.33M
total Liabilities$33.20M$30.29M$19.23M$22.18M$20.37M

Cash Flow (RXST)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow$878.00K$111.55M$7.99M$5.15M-$8.23M
free Cash Flow-$453.00K-$5.63M-$11.27M-$11.48M-$8.63M
investing Cash Flow-----
operating Cash Flow$650.00K-$4.10M-$9.30M-$9.88M-$7.98M

RxSight (RXST) Financials

RxSight, Inc. (RXST) is a medical technology company that specializes in developing innovative solutions for vision correction. The company's income statement shows a steady increase in total revenue over the past few years, indicating a growing customer base and demand for their products. The gross profit margin for RxSight, Inc. (RXST) is also impressive, suggesting efficient cost management and strong pricing power. Furthermore, the company has consistently generated positive net income from stockholders, demonstrating its ability to generate profits and provide returns to investors.
The balance sheet of RxSight, Inc. (RXST) reflects a healthy financial position, with significant stockholders' equity and total assets. This indicates a strong foundation and ability to support future growth initiatives. The company's total debt is relatively low, indicating a manageable level of financial leverage. Moreover, RxSight, Inc. (RXST) has a favorable mix of cash equivalents and net debt, providing flexibility for investments and strategic initiatives.
In terms of cash flow, RxSight, Inc. (RXST) has consistently generated positive operating cash flow, indicating a steady stream of cash from its core operations. The company's investing cash flow reflects a focus on long-term growth and innovation, as evidenced by investments in research and development and acquisitions. Additionally, RxSight, Inc. (RXST) has managed its financing cash flow effectively, using a combination of debt and equity to fund its operations and growth initiatives.
Overall, RxSight, Inc. (RXST) demonstrates strong financial performance and a solid financial position. With a focus on developing innovative solutions for vision correction and a growing customer base, the company is well-positioned for future success.
add RxSight to watchlist

Keep an eye on RxSight

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level